Scholar Rock Holding (SRRK) EPS (Basic) (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly EPS (Basic) came in at -$0.8 in Q1 2026, down 19.0% year-on-year from -$0.98 in Q1 2025, and down 2.17% quarter-over-quarter from -$0.78 in Q4 2025.
Scholar Rock Holding (SRRK) EPS (Basic) (2017 - 2026) Analysis & Trends
Scholar Rock Holding's EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.8 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 19.0% year-over-year to -$0.8 in Q1 2026; TTM through Mar 2026 was -$5.62, a 134.03% decrease from a year earlier, with the FY2025 full-year figure at -$3.29, down 33.49% from the prior year.
- EPS (Basic) declined to -$0.8 in Q1 2026 per SRRK's latest filing, from -$0.78 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.25 in Q1 2022 and bottomed at -$2.34 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.67 (2025), against an average of -$0.84.
- Across the five-year window, EPS (Basic) soared 93.88% in 2022 and plunged 275.8% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.7 in 2022, then increased by 14.92% to -$0.6 in 2023, then fell by 13.67% to -$0.68 in 2024, then fell by 15.12% to -$0.78 in 2025, then slipped by 2.17% to -$0.8 in 2026.
- Per Business Quant, the three latest SRRK EPS (Basic) figures stand at -$0.8 (Q1 2026), -$0.78 (Q4 2025), and -$2.29 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Scholar Rock Holding | 6.10 Bn | 6.10 Bn | - | -0.80 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.80 |
| Dec 31, 2025 | -0.78 |
| Sep 30, 2025 | -2.29 |
| Jun 30, 2025 | -2.34 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | -0.68 |
| Sep 30, 2024 | -0.68 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.53 |
| Mar 31, 2023 | -0.56 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.59 |
| Jun 30, 2022 | -1.05 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.98 |
| Sep 30, 2021 | -2.39 |
| Jun 30, 2021 | -2.11 |